Secarna Pharmaceuticals and Achilles Therapeutics sign Multiple Agreement to Develop Optimized T cell Therapies
Secarna to receive an upfront along with an option exercise fees & is also eligible to receive development & commercial milestone along…
Secarna to receive an upfront along with an option exercise fees & is also eligible to receive development & commercial milestone along…
KEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a strategic…